|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao L and Zheng XY: MicroRNA-490 inhibits
tumorigenesis and progression in breast cancer. Onco Targets Ther.
9:4505–4516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rudolph A, Chang-Claude J and Schmidt MK:
Gene-environment interaction and risk of breast cancer. Br J
Cancer. 114:125–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu RZ, Garcia E, Glubrecht DD, Poon HY,
Mackey JR and Godbout R: CRABP1 is associated with a poor prognosis
in breast cancer: Adding to the complexity of breast cancer cell
response to retinoic acid. Mol Cancer. 14:1292015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong Y, Chang C, Liu J and Qiang J:
Targeting of GIT1 by miR-149* in breast cancer suppresses cell
proliferation and metastasis in vitro and tumor growth in vivo.
Onco Targets Ther. 10:5873–5882. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: LncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu B, Li J and Cairns MJ: Identifying
miRNAs, targets and functions. Brief Bioinform. 15:1–19. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song B, Lin HX, Dong LL, Ma JJ and Jiang
ZG: MicroRNA-338 inhibits proliferation, migration, and invasion of
gastric cancer cells by the Wnt/β-catenin signaling pathway. Eur
Rev Med Pharmacol Sci. 22:1290–1296. 2018.PubMed/NCBI
|
|
11
|
Li N, Han M, Zhou N, Tang Y and Tang XS:
MicroRNA-495 confers increased sensitivity to chemotherapeutic
agents in gastric cancer via the mammalian target of rapamycin
(mTOR) signaling pathway by interacting with human epidermal growth
factor receptor 2 (ERBB2). Med Sci Monit. 24:5960–5972. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai D, Sun H, Wang X, Lou H, Zhang J, Wang
X and Jiang L: MiR-150 inhibits cell growth in vitro and in vivo by
restraining the RAB11A/WNT/β-catenin pathway in thyroid cancer. Med
Sci Monit. 23:4885–4894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song L, Dai Z, Zhang S, Zhang H, Liu C, Ma
X, Liu D, Zan Y and Yin X: MicroRNA-1179 suppresses cell growth and
invasion by targeting sperm-associated antigen 5-mediated Akt
signaling in human non-small cell lung cancer. Biochem Biophys Res
Commun. 504:164–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Wang Y, Fan H, Zhang Z and Li N:
miR-125b-5p inhibits breast cancer cell proliferation, migration
and invasion by targeting KIAA1522. Biochem Biophys Res Commun.
504:277–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong Y, Zheng Y, Wang C, Ding X, Du Y, Liu
L, Zhang W, Zhang W, Zhong Y, Wu Y and Song X: MiR-876-5p modulates
head and neck squamous cell carcinoma metastasis and invasion by
targeting vimentin. Cancer Cell Int. 18:1212018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Xie Y, Li X, Lin J, Zhang S, Li Z,
Huo L and Gong R: MiR-876-5p acts as an inhibitor in hepatocellular
carcinoma progression by targeting DNMT3A. Pathol Res Pract.
214:1024–1030. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bao L, Lv L, Feng J, Chen Y, Wang X, Han S
and Zhao H: MiR-876-5p suppresses epithelial-mesenchymal transition
of lung cancer by directly down-regulating bone morphogenetic
protein 4. J Biosci. 42:671–681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nagasawa S, Sedukhina AS, Nakagawa Y,
Maeda I, Kubota M, Ohnuma S, Tsugawa K, Ohta T, Roche-Molina M,
Bernal JA, et al: LSD1 overexpression is associated with poor
prognosis in basal-like breast cancer, and sensitivity to PARP
inhibition. PLoS One. 10:e01180022015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Yin W, Lin Y, Yin K, Zhou L, Du Y,
Yan T and Lu J: Downregulated circulating microRNAs after surgery:
Potential noninvasive biomarkers for diagnosis and prognosis of
early breast cancer. Cell Death Discov. 4:212018. View Article : Google Scholar
|
|
21
|
Xu Q, Zhu Q, Zhou Z, Wang Y, Liu X, Yin G,
Tong X and Tu K: MicroRNA-876-5p inhibits epithelial-mesenchymal
transition and metastasis of hepatocellular carcinoma by targeting
BCL6 corepressor like 1. Biomed Pharmacother. 103:645–652. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu DX, Guo JJ, Zhu GY, Wu HJ, Zhang QS and
Cui T: MiR-363-3p modulates cell growth and invasion in glioma by
directly targeting pyruvate dehydrogenase B. Eur Rev Med Pharmacol
Sci. 22:5230–5239. 2018.PubMed/NCBI
|
|
23
|
Rehei AL, Zhang L, Fu YX, Mu WB, Yang DS,
Liu Y, Zhou SJ and Younusi A: MicroRNA-214 functions as an oncogene
in human osteosarcoma by targeting TRAF3. Eur Rev Med Pharmacol
Sci. 22:5156–5164. 2018.PubMed/NCBI
|
|
24
|
Xu J, Wang F, Wang X, He Z and Zhu X:
miRNA-543 promotes cell migration and invasion by targeting SPOP in
gastric cancer. Onco Targets Ther. 11:5075–5082. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z, Li J, Huang Y, Peng W, Qian W, Gu
J, Wang Q, Hu T, Ji D, Ji B, et al: Upregulated miR-1258 regulates
cell cycle and inhibits cell proliferation by directly targeting
E2F8 in CRC. Cell Prolif. 51:e125052018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuan J, Zhang N, Zheng Y, Chen YD, Liu J
and Yang M: LncRNA GAS5 indel genetic polymorphism contributes to
glioma risk through interfering binding of transcriptional factor
TFAP2A. DNA Cell Biol. 37:750–757. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi D, Xie F, Zhang Y, Tian Y, Chen W, Fu
L, Wang J, Guo W, Kang T, Huang W and Deng W: TFAP2A regulates
nasopharyngeal carcinoma growth and survival by targeting
HIF-1alpha signaling pathway. Cancer Prev Res (Phila.). 7:266–277.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Allouche A, Nolens G, Tancredi A,
Delacroix L, Mardaga J, Fridman V, Winkler R, Boniver J, Delvenne P
and Begon DY: The combined immunodetection of AP-2alpha and YY1
transcription factors is associated with ERBB2 gene overexpression
in primary breast tumors. Breast Cancer Res. 10:R92008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yan F, He Q, Hu X, Li W, Wei K, Li L,
Zhong Y, Ding X, Xiang S and Zhang J: Direct regulation of caspase3
by the transcription factor AP2α is involved in aspirininduced
apoptosis in MDAMB453 breast cancer cells. Mol Med Rep. 7:909–914.
2013. View Article : Google Scholar : PubMed/NCBI
|
